Skip to main content

Month: February 2026

Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2026 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced multiple upcoming posters highlighting bezuclastinib results from the SUMMIT trial in NonAdvanced Systemic Mastocytosis (NonAdvSM) patients at the 2026 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) being held in Philadelphia, PA, February 27-March 2, 2026. In December 2025, Cogent announced that the company submitted its New Drug Application for bezuclastinib in NonAdvSM to the U.S. Food and Drug Administration. The submission is based on positive clinical data from the SUMMIT pivotal trial and follows the Breakthrough Therapy Designation for bezuclastinib in patients with SSM...

Continue reading

INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB

Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA), designed to streamline the final approval process and reduce time to market Boca Raton, FL, Feb. 10, 2026 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, today announced a critical step toward the commercialization of CORDStrom™ for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).  The Company has formally submitted its pre-submission package for CORDStrom with the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA). This early engagement step is designed to solicit targeted scientific, regulatory, and procedural feedback, streamlining the...

Continue reading

Revau Advanced Underwriting Announces Acquisition of Triad Oilfield Underwriters, Expanding Specialty Capabilities in U.S. Oil & Gas and Marine Risks

Houston-based MGA and wholesale platform strengthens Revau’s U.S. footprint, marking Revau’s 3rd MGA acquisition in the country MONTREAL, Feb. 10, 2026 (GLOBE NEWSWIRE) — Revau, a North American managing general agent (MGA) specializing in property and casualty insurance, today announced the acquisition of Triad Oilfield Underwriters, a Houston-based MGA and wholesale insurance brokerage focused on oil & gas and marine risks. Established in 2017 and expanded through its 2022 merger with Bayshore Underwriters, Triad works closely with retail and wholesale brokers to underwrite and place complex upstream oil & gas and marine risks. As a Lloyd’s of London coverholder, Triad holds delegated underwriting authority and maintains longstanding relationships with leading specialty capacity providers. Triad also offers a specialty...

Continue reading

AFC Commits $29 Million to a Senior Term Loan for a Sponsor Acquisition

Supports the Acquisition and Growth of a Leading Healthcare Benefits Platform and Demonstrates AFC’s Expanded Investment Mandate as a BDC WEST PALM BEACH, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) — AFC today announced that it has committed $29 million to a $60 million senior secured term loan.  The proceeds from the credit facility, including $19.6 million funded by AFC at close, will be used to finance the acquisition of a leading healthcare benefits platform (the “Platform”). “We are excited to support a top-tier sponsor and management team in this transaction. The Platform has developed a comprehensive benefits program tailored toward a large and underserved segment of the workforce,” said Daniel Neville, Chief Executive Officer of AFC. “This transaction underscores our ability to provide flexible, institutional capital to sponsors...

Continue reading

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024.Reports record GAAP diluted EPS of $0.50 and non-GAAP diluted EPS of $0.54 for the fourth quarter of 2025, which are increases of 25% and 23%, respectively, compared to the same period in 2024.Reports record GAAP diluted EPS of $1.75 and non-GAAP diluted EPS of $1.93 for the full year of 2025, which are increases of 17% and 16%, respectively, compared to the full year of 2024.Declares a regular quarterly cash dividend of $0.20 per share of common stock for the fourth quarter of 2025, payable on March 6, 2026.ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter...

Continue reading

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026 Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performanceHOLLISTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended December 31, 2025. In conjunction with these results, the Company outlined a cohesive long-term strategy designed to leverage its market-leading...

Continue reading

Fancamp Announces Leadership Appointments to Goldera Exploration Ltd. as part of Corporate Reorganization

VANCOUVER, British Columbia, Feb. 10, 2026 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the leadership team for the Corporation’s newly incorporated subsidiary, Goldera Exploration Ltd. (“Goldera”), as part of a strategic reorganization of the Corporation’s assets pursuant to which the Corporation would spin out (the “Spin-Out”) its interests in core exploration projects (the “Exploration Assets”) into Goldera, with the intent of listing Goldera on the TSX Venture Exchange (the “TSXV”). Goldera’s Board shall constitute four members, being Rajesh Sharma, Charles Tarnocai, Mark Billings, and Mathieu Stephens. The following Officers have been appointed as Goldera’s management, namely Rajesh Sharma, Executive Chairman, Charles Tarnocai, Chief Executive...

Continue reading

Surge Copper Announces $15 Million Private Placement to Advance Berg Project

Not for distribution to U.S. newswire services or dissemination in the United States Vancouver, British Columbia, Feb. 10, 2026 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce a non-brokered private placement of 30 million units (the “Units”) at a price of $0.50 per Unit for gross proceeds of $15 million (the “Offering”). Each Unit will comprise one common share of the Company and one non-transferable common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one additional common share of the Company at an exercise price of $1.00 per share for a period of three years from the date of issuance (subject to acceleration). The Warrants will be subject to an acceleration provision whereby, if at any time following...

Continue reading

Samfine Creation Holdings Group Limited: Exploring “Printing + IP + Ecosystem” as a Strategic Direction for Chinese Cultural Creative Products

HONG KONG, Feb. 10, 2026 (GLOBE NEWSWIRE) — Samfine Creation Holdings Group Limited (Nasdaq: SFHG, “Samfine”or the “Company”) is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. With over 20 years of experience in the printing industry, the Company offers a wide range of printed products such as books as well as novelty and packaging products. Building on its existing printing capabilities, the Company is committed to extending its industrial chain upstream. Recently, Mrs. Cheng Kwan Hong, the general manager and the Director of the Company, shared management’s perspective on this strategic direction. “This development direction reflects our assessment of the company’s existing capabilities and evolving market conditions,” Mrs. Cheng Kwan Hong, the general...

Continue reading

Recording of LHV Group’s 10 February investor webinar

To give an overview of the 2025 Q4 and 12 month financial results, LHV Group organised an investor meeting webinar on 10 February. An overview of the company’s progress was given by Mihkel Torim (CEO of LHV Group), Meelis Paakspuu (CFO of LHV Group), Kadri Kiisel (CEO of LHV Pank) and Erki Kilu (CEO of LHV Bank). Recording of the investor meeting (in English) is available at: https://www.youtube.com/watch?v=vBsAE9CzI40 Presentation (in English) at: www.lhv.ee/assets/files/investor/LHV_Group_Investoresitlus_2025-Q4_EN.pdf LHV Group is the largest domestic financial group and capital provider in Estonia. LHV Group’s key subsidiaries are LHV Pank, LHV Varahaldus, LHV Kindlustus, and LHV Bank Limited. The Group employs approximately 1,200 people. As at the end of December, the services of LHV Pank are being used by 492,000 customers,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.